{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:55:31Z","timestamp":1786118131582,"version":"build-2736575974"},"reference-count":116,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010023","name":"Natural Science Research of Jiangsu Higher Education Institutions of China","doi-asserted-by":"publisher","award":["24KJB350003"],"award-info":[{"award-number":["24KJB350003"]}],"id":[{"id":"10.13039\/501100010023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013280","name":"Major Basic Research Project of the Natural Science Foundation of the Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tips.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:39:25Z","timestamp":1783399165000},"page":"855-870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering cells for solid tumor therapy"],"prefix":"10.1016","volume":"47","author":[{"given":"Yuyang","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingtong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.06.002_bb0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","article-title":"The entry of nanoparticles into solid tumours","volume":"19","author":"Sindhwani","year":"2020","journal-title":"Nat. Mater."},{"key":"10.1016\/j.tips.2026.06.002_bb0010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/acscentsci.6b00190","article-title":"Does nanomedicine have a delivery problem?","volume":"2","author":"Torrice","year":"2016","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.tips.2026.06.002_bb0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tips.2026.06.002_bb0020","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2220173120","article-title":"Reverse-QTY code design of active human serum albumin self-assembled amphiphilic nanoparticles for effective anti-tumor drug doxorubicin release in mice","volume":"120","author":"Meng","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.06.002_bb0025","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2319880121","article-title":"Curvature-mediated rapid extravasation and penetration of nanoparticles against interstitial fluid pressure for improved drug delivery","volume":"121","author":"Jiang","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.06.002_bb0030","first-page":"356","article-title":"A real-world cohort study of immune-related adverse events in patients receiving immune checkpoint inhibitors","volume":"9","author":"Wang","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.tips.2026.06.002_bb0035","article-title":"Systemic tumor suppression via macrophage-driven automated homing of metal-phenolic-gated nanosponges for metastatic melanoma","volume":"10","author":"Liao","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.06.002_bb0040","article-title":"Harnessing anti-tumor and tumor-tropism functions of macrophages via nanotechnology for tumor immunotherapy","volume":"2","author":"Zheng","year":"2022","journal-title":"Exploration"},{"key":"10.1016\/j.tips.2026.06.002_bb0045","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41551-024-01230-6","article-title":"Cell\u2013drug conjugates","volume":"8","author":"Wang","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.tips.2026.06.002_bb0050","article-title":"A novel engineering cell therapy platform mimicking the immune thrombocytopenia-derived platelets to inhibit cytokine storm in hemophagocytic lymphohistiocytosis","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.06.002_bb0055","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2026.06.002_bb0060","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tips.2026.06.002_bb0065","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tips.2026.06.002_bb0070","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abn6612","article-title":"Selective STING stimulation in dendritic cells primes antitumor T cell responses","volume":"8","author":"Jneid","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.tips.2026.06.002_bb0075","doi-asserted-by":"crossref","DOI":"10.1002\/agt2.194","article-title":"Therapeutic dendritic cell vaccines engineered with antigen-biomineralized Bi2S3 nanoparticles for personalized tumor radioimmunotherapy","volume":"3","author":"Yu","year":"2022","journal-title":"Aggregate"},{"key":"10.1016\/j.tips.2026.06.002_bb0080","article-title":"Harnessing nanotheranostics-based dendritic cells tracking mature tertiary lymphoid structures to boost anti-glioma immunotherapy","volume":"35","author":"Zhang","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.tips.2026.06.002_bb0085","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1039\/D4SC07198K","article-title":"Engineering live cell surfaces with polyphenol-functionalized nanoarchitectures","volume":"16","author":"He","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.tips.2026.06.002_bb0090","doi-asserted-by":"crossref","first-page":"13175","DOI":"10.1021\/acsnano.4c18465","article-title":"Modulating intracellular autophagy and macropinocytosis for increased neighboring drug delivery","volume":"19","author":"Feng","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.002_bb0095","doi-asserted-by":"crossref","first-page":"10918","DOI":"10.1021\/acsnano.2c03311","article-title":"Enhancing adoptive cell therapy by T cell loading of SHP2 inhibitor nanocrystals before infusion","volume":"16","author":"Li","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.002_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202003492","article-title":"Engineering of living cells with polyphenol-functionalized biologically active nanocomplexes","volume":"32","author":"Zhao","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tips.2026.06.002_bb0105","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1021\/acsnano.2c03573","article-title":"Live macrophage-delivered doxorubicin-loaded liposomes effectively treat triple-negative breast cancer","volume":"16","author":"Yang","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.002_bb0110","doi-asserted-by":"crossref","first-page":"8492","DOI":"10.1021\/acsnano.1c00114","article-title":"Primary macrophage-based microrobots: an effective tumor therapy in vivo by dual-targeting function and near-infrared-triggered drug release","volume":"15","author":"Nguyen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.002_bb0115","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1038\/s41591-023-02452-y","article-title":"Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1\/2 trial interim results","volume":"29","author":"Hassan","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2026.06.002_bb0120","doi-asserted-by":"crossref","first-page":"14441","DOI":"10.1021\/acsnano.4c01120","article-title":"Pluronic-based nanoparticles for delivery of doxorubicin to the tumor microenvironment by binding to macrophages","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.002_bb0125","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/s41423-024-01228-9","article-title":"Specific ECM degradation potentiates the antitumor activity of CAR-T cells in solid tumors","volume":"21","author":"Zheng","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.tips.2026.06.002_bb0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41392-022-01058-z","article-title":"Natural killer cell homing and trafficking in tissues and tumors: from biology to application","volume":"7","author":"Ran","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.tips.2026.06.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202400149","article-title":"pH-sensitive magnetic nanoparticle-mediated natural-killer-cell-based microrobots for dual-targeted delivery and induction of pro-inflammatory macrophage polarization","volume":"5","author":"Nguyen","year":"2024","journal-title":"Small Struct."},{"key":"10.1016\/j.tips.2026.06.002_bb0140","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41565-025-01924-1","article-title":"A collagenase nanogel backpack improves CAR-T cell therapy outcomes in pancreatic cancer","volume":"20","author":"Zhao","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.tips.2026.06.002_bb0145","doi-asserted-by":"crossref","first-page":"14531","DOI":"10.1021\/acs.nanolett.4c03678","article-title":"Small-molecule therapeutics achieve multiple mechanism-mediated sensitizations of colorectal cancer to immune checkpoint blockade via neutrophil micropharmacies","volume":"24","author":"Li","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.tips.2026.06.002_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113679","article-title":"DNA scaffold-framed natural killer cell with programmed drug release for chemo-adoptive cell therapy","volume":"382","author":"Bi","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2026.06.002_bb0155","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1016\/j.apsb.2024.08.033","article-title":"Localized light-triggered release macrophage cytopharmaceuticals containing O-nitrobenzyl group for enhanced solid tumor cell-chemotherapy","volume":"14","author":"Liu","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tips.2026.06.002_bb0160","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cell.2022.03.030","article-title":"Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis","volume":"185","author":"Pan","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.06.002_bb0165","article-title":"Macrophages-based biohybrid microrobots for breast cancer photothermal immunotherapy by inducing pyroptosis","volume":"20","author":"Xing","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.tips.2026.06.002_bb0170","article-title":"Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering","volume":"9","author":"Li","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2026.06.002_bb0175","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/s41467-025-56637-9","article-title":"Harnessing macrophage-drug conjugates for allogeneic cell-based therapy of solid tumors via the TRAIN mechanism","volume":"16","author":"Taciak","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.002_bb0180","doi-asserted-by":"crossref","DOI":"10.1126\/scirobotics.aaz9519","article-title":"Dual-responsive biohybrid neutrobots for active target delivery","volume":"6","author":"Zhang","year":"2021","journal-title":"Sci. Robot."},{"key":"10.1016\/j.tips.2026.06.002_bb0185","doi-asserted-by":"crossref","first-page":"13894","DOI":"10.1021\/acsnano.0c06290","article-title":"A smart nanoparticle-laden and remote-controlled self-destructive macrophage for enhanced chemo\/chemodynamic synergistic therapy","volume":"14","author":"Sun","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.002_bb0190","doi-asserted-by":"crossref","first-page":"49362","DOI":"10.1021\/acsami.0c12849","article-title":"Effectual labeling of natural killer cells with upconverting nanoparticles by electroporation for in vivo tracking and biodistribution assessment","volume":"12","author":"Park","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.tips.2026.06.002_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101542","article-title":"Enhanced B cell electroporation efficiency via inhibition of DNA-induced apoptosis and pyroptosis with pan-caspase inhibitor","volume":"33","author":"Yang","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tips.2026.06.002_bb0200","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1021\/acs.biomac.3c01373","article-title":"Optimized design of hyaluronic acid-lipid conjugate biomaterial for augmenting CD44 recognition of surface-engineered NK cells","volume":"25","author":"Park","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.tips.2026.06.002_bb0205","doi-asserted-by":"crossref","first-page":"15918","DOI":"10.1021\/acsnano.3c03980","article-title":"Polymer micropatches as natural killer cell engagers for tumor therapy","volume":"17","author":"Prakash","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.002_bb0210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12951-019-0440-z","article-title":"T cells loaded with magnetic nanoparticles are retained in peripheral lymph nodes by the application of a magnetic field","volume":"17","author":"Sanz-Ortega","year":"2019","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.tips.2026.06.002_bb0215","article-title":"Mutual destruction of deep lung tumor tissues by nanodrug-conjugated stealth mesenchymal stem cells","volume":"5","author":"Kim","year":"2018","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.06.002_bb0220","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/acs.molpharmaceut.4c01396","article-title":"RBCs as a bioinspired drug delivery system for co-delivery of irinotecan and nanoalumina enhances colorectal cancer therapy","volume":"22","author":"Zhong","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.tips.2026.06.002_bb0225","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/s41467-026-68490-5","article-title":"In situ self-assembled cell reservoir hydrogel for maneuvering multistage radioimmunotherapy","volume":"17","author":"Chen","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.002_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1008","article-title":"DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia","volume":"13","author":"Lam","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2026.06.002_bb0235","first-page":"1528","article-title":"Cell relay-delivery improves targeting and therapeutic efficacy in tumors","volume":"6","author":"Feng","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.tips.2026.06.002_bb0240","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jconrel.2024.02.003","article-title":"Genetically engineered macrophages as living cell drug carriers for targeted cancer therapy","volume":"367","author":"Ning","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2026.06.002_bb0245","article-title":"Macrophage-mediated delivery of hypoxia-activated prodrug nanoparticles","volume":"3","author":"Evans","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.tips.2026.06.002_bb0250","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1021\/acsabm.3c00985","article-title":"Uptake of cyclodextrin nanoparticles by macrophages is dependent on particle size and receptor-mediated interactions","volume":"7","author":"Soni","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.tips.2026.06.002_bb0255","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41467-025-56404-w","article-title":"Force-bearing phagocytic adhesion rings mediate the phagocytosis of surface-bound particles","volume":"16","author":"Kundu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.002_bb0260","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jconrel.2023.08.014","article-title":"Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells","volume":"361","author":"Douka","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2026.06.002_bb0265","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.1038\/s41467-021-24564-0","article-title":"Engineered macrophages as near-infrared light activated drug vectors for chemo-photodynamic therapy of primary and bone metastatic breast cancer","volume":"12","author":"Huang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.002_bb0270","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1021\/acscentsci.2c00163","article-title":"Bioorthogonal equipping CAR-T cells with hyaluronidase and checkpoint blocking antibody for enhanced solid tumor immunotherapy","volume":"8","author":"Zhao","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.tips.2026.06.002_bb0275","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ymthe.2024.02.026","article-title":"Stem cell-derived CAR T cells show greater persistence, trafficking, and viral control compared to ex vivo transduced CAR T cells","volume":"32","author":"Carrillo","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2026.06.002_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113779","article-title":"Sequentially conquering transfection obstacles of primary human T cells via non-classical lipid nanoparticles delivering reformative transposon system","volume":"383","author":"Wu","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2026.06.002_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg2697","article-title":"d-Lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma","volume":"9","author":"Han","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2026.06.002_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111128","article-title":"Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy","volume":"40","author":"Chang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2026.06.002_bb0295","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41419-025-08405-2","article-title":"A new strategy for CAR-T therapy in solid tumors: IL-15-autocrine signaling augments tumor stroma depletion and promotes a TSCM subset in the TME","volume":"17","author":"Pang","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tips.2026.06.002_bb0300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13045-024-01559-0","article-title":"Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy","volume":"17","author":"Toledo","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.tips.2026.06.002_bb0305","article-title":"Surface molecularly engineered mitochondria conduct immunophenotype repolarization of tumor-associated macrophages to potentiate cancer immunotherapy","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.06.002_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2021.129273","article-title":"Macrophages loaded with dendrimer-entrapped gold nanoparticles as a theranostic platform for CT imaging-guided combinational therapy of orthotopic osteosarcoma","volume":"417","author":"Yin","year":"2021","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.tips.2026.06.002_bb0315","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12943-024-02154-0","article-title":"Membrane-bound IL-7 immobilized by the CD8 transmembrane region improves efficacy of CD19 CAR-T cell therapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tips.2026.06.002_bb0320","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1038\/s41467-024-48653-y","article-title":"Deleting the mitochondrial respiration negative regulator MCJ enhances the efficacy of CD8+ T cell adoptive therapies in pre-clinical studies","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.002_bb0325","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40820-020-00555-6","article-title":"Nanoparticle-mediated lipid metabolic reprogramming of T cells in tumor microenvironments for immunometabolic therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Nano Micro Lett."},{"key":"10.1016\/j.tips.2026.06.002_bb0330","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.it.2024.07.009","article-title":"The extracellular matrix in solid tumor immunotherapy","volume":"45","author":"Cho","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.tips.2026.06.002_bb0335","article-title":"Hyperbaric oxygen boosts PD-1 antibody delivery and T cell infiltration for augmented immune responses against solid tumors","volume":"8","author":"Liu","year":"2021","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.06.002_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108163","article-title":"Overcoming stromal resistance in solid tumors with MMP2-engineered CAR-T cells","volume":"226","author":"Tu","year":"2026","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tips.2026.06.002_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.119928","article-title":"Quantum dot-pulsed dendritic cell vaccines plus macrophage polarization for amplified cancer immunotherapy","volume":"242","author":"Liu","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.tips.2026.06.002_bb0350","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aeb7714","article-title":"Nanocollision promotes locomotion of dendritic cells for tumor therapy","volume":"12","author":"Zhu","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2026.06.002_bb0355","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41578-023-00617-2","article-title":"Responsive biomaterials: optimizing control of cancer immunotherapy","volume":"9","author":"Xue","year":"2024","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.tips.2026.06.002_bb0360","article-title":"IL-21 loading CaMnCO3 vitality backpacks boost CAR-T cell synergistic immunotherapy","volume":"21","author":"Wang","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.tips.2026.06.002_bb0365","article-title":"Spatiotemporally controlled T-cell combination therapy for solid tumor","volume":"11","author":"Hao","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.06.002_bb0370","article-title":"Dual enzyme-responsive polymer-drug conjugates induce diverse cells mutual transcytosis to achieve deep pancreatic tumor penetration","volume":"64","author":"Sun","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.tips.2026.06.002_bb0375","article-title":"A dual-responsive versatile nanohybrid orchestrating tumor elimination and tumor-associated osteolysis restoration via sequential release","volume":"13","author":"Liu","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.06.002_bb0380","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1021\/acsnano.5c18698","article-title":"Supramolecular metallacycle enables esterase-responsive and endoplasmic reticulum-associated pathway activation for synergistic photothermal immunotherapy","volume":"20","author":"Chen","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.002_bb0385","doi-asserted-by":"crossref","first-page":"7369","DOI":"10.1038\/s41467-024-51620-2","article-title":"Ultrasound-mediated spatial and temporal control of engineered cells in vivo","volume":"15","author":"Ivanovski","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.002_bb0390","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2022.04.038","article-title":"A mutually beneficial macrophages-mediated delivery system realizing photo\/immune therapy","volume":"347","author":"Wang","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2026.06.002_bb0395","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1038\/s41467-025-58184-9","article-title":"On-demand treatment of metabolic diseases by a synthetic drug-inducible exocytosis system","volume":"16","author":"Si","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.002_bb0400","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202400425","article-title":"Modulating intracellular dynamics for optimized intracellular release and transcytosis equilibrium","volume":"36","author":"Yuan","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tips.2026.06.002_bb0405","article-title":"Regulation of cargo exocytosis by a Reps1-Ralbp1-RalA module","volume":"9","author":"Wang","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.tips.2026.06.002_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113460","article-title":"Copine-6 is a Ca2+ sensor for activity-induced AMPA receptor exocytosis","volume":"42","author":"Tan","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.tips.2026.06.002_bb0415","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202407068","article-title":"MYO18B promotes lysosomal exocytosis by facilitating focal adhesion maturation","volume":"224","author":"Ren","year":"2025","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2026.06.002_bb0420","doi-asserted-by":"crossref","first-page":"19096","DOI":"10.1021\/acsnano.2c08146","article-title":"Nanocarrier-assisted delivery of metformin boosts remodeling of diabetic periodontal tissue via cellular exocytosis-mediated regulation of endoplasmic reticulum homeostasis","volume":"16","author":"Zhong","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.002_bb0425","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41591-024-02826-w","article-title":"T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy","volume":"30","author":"Ghilardi","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2026.06.002_bb0430","first-page":"2698","article-title":"Novel extragenic genomic safe harbors for precise therapeutic T-cell engineering","volume":"141","author":"Odak","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.tips.2026.06.002_bb0435","article-title":"Human stem cells with in vivo high plasticity generated by cell\u2013cell communication","volume":"122","author":"Li","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.06.002_bb0440","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.stem.2025.03.003","article-title":"A call to action for deciphering genetic variants in human pluripotent stem cells for cell therapy","volume":"32","author":"Benvenisty","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tips.2026.06.002_bb0445","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/s41591-023-02404-6","article-title":"CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results","volume":"29","author":"Park","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2026.06.002_bb0450","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41591-024-03109-0","article-title":"Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results","volume":"30","author":"Parkhurst","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2026.06.002_bb0455","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2312374120","article-title":"Dual-inhibitory domain iCARs improve the efficiency of the AND-NOT gate CAR T strategy","volume":"120","author":"Bangayan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.06.002_bb0460","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2405085121","article-title":"Dual ON\/OFF-switch chimeric antigen receptor controlled by two clinically approved drugs","volume":"121","author":"Giordano Attianese","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.06.002_bb0465","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ccell.2022.08.008","article-title":"High-performance multiplex drug-gated CAR circuits","volume":"40","author":"Li","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2026.06.002_bb0470","first-page":"1227","article-title":"Targeting TGF\u03b2-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome","volume":"5","author":"Vinnakota","year":"2024","journal-title":"Nat. Can."},{"key":"10.1016\/j.tips.2026.06.002_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202201042","article-title":"Magnetic-powered janus cell robots loaded with oncolytic adenovirus for active and targeted virotherapy of bladder cancer","volume":"34","author":"Cong","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.tips.2026.06.002_bb0480","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1016\/j.ymthe.2022.04.015","article-title":"Dual-aptamer-engineered M1 macrophage with enhanced specific targeting and checkpoint blocking for solid-tumor immunotherapy","volume":"30","author":"Qian","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2026.06.002_bb0485","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.1038\/s41467-022-33891-9","article-title":"Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy","volume":"13","author":"Yu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.002_bb0490","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1016\/j.cell.2022.11.016","article-title":"Engineered cell entry links receptor biology with single-cell genomics","volume":"185","author":"Yu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.tips.2026.06.002_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102610","article-title":"Lipid nanoparticles produce chimeric antigen receptor macrophages (CAR-M) in situ for the treatment of solid tumors","volume":"61","author":"Zhou","year":"2025","journal-title":"Nano Today"},{"key":"10.1016\/j.tips.2026.06.002_bb0500","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41591-022-02182-7","article-title":"Allogeneic BCMA-targeting CAR T cells in relapsed\/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results","volume":"29","author":"Mailankody","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2026.06.002_bb0505","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41587-023-01784-x","article-title":"Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques","volume":"42","author":"Hu","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2026.06.002_bb0510","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1038\/s41467-025-60816-z","article-title":"Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny","volume":"16","author":"Nowicki","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2026.06.002_bb0515","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-024-02979-8","article-title":"PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial","volume":"30","author":"Dorff","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2026.06.002_bb0520","article-title":"Microfluidics-enabled nanovesicle delivers CD47\/PD-L1 antibodies to enhance antitumor immunity and reduce immunotoxicity in lung adenocarcinoma","volume":"10","author":"Su","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.tips.2026.06.002_bb0525","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1056\/NEJMoa2210859","article-title":"GD2-CART01 for relapsed or refractory high-risk neuroblastoma","volume":"388","author":"Del Bufalo","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tips.2026.06.002_bb0530","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jconrel.2021.12.022","article-title":"Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect","volume":"341","author":"Zhu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.tips.2026.06.002_bb0535","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ccell.2025.10.014","article-title":"A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma","volume":"44","author":"Rade","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tips.2026.06.002_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202502210","article-title":"Microfluidic hydroporation platform for effective allogeneic CAR-T cell production and subsequent functional cytotoxicity analysis","volume":"11","author":"Jeon","year":"2026","journal-title":"Adv. Mater. Technol."},{"key":"10.1016\/j.tips.2026.06.002_bb0545","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41591-025-03640-8","article-title":"Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial","volume":"31","author":"Nieto","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.tips.2026.06.002_bb0550","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41408-025-01225-9","article-title":"Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel","volume":"15","author":"Dulobdas","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.tips.2026.06.002_bb0555","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/s41375-022-01545-w","article-title":"Autologous or allogeneic hematopoietic cell transplantation for relapsed or refractory PTCL-NOS or AITL","volume":"36","author":"Kameda","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.tips.2026.06.002_bb0560","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.7150\/thno.125983","article-title":"CAR-T manufacturing reduces heterogeneity between CIDP and multiple myeloma patient-derived T cells","volume":"16","author":"Wang","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.tips.2026.06.002_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101224","article-title":"Automated manufacture of \u0394NPM1 TCR-engineered T cells for AML therapy","volume":"32","author":"Yonezawa Ogusuku","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tips.2026.06.002_bb0570","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41421-023-00546-y","article-title":"Design of a palette of SNAP-tag mimics of fluorescent proteins and their use as cell reporters","volume":"9","author":"Zhang","year":"2023","journal-title":"Cell Discov."},{"key":"10.1016\/j.tips.2026.06.002_bb0575","doi-asserted-by":"crossref","first-page":"7401","DOI":"10.1021\/acsnano.5c10637","article-title":"Cryo-correlative light and X-ray microscopies: expanding the intracellular chemical map","volume":"20","author":"Karpov","year":"2026","journal-title":"ACS Nano"},{"key":"10.1016\/j.tips.2026.06.002_bb0580","doi-asserted-by":"crossref","first-page":"8809","DOI":"10.1038\/s41467-025-63863-8","article-title":"Selective HLA knockdown and PD-L1 expression prevent allogeneic CAR-NK cell rejection and enhance safety and anti-tumor responses in xenograft mice","volume":"16","author":"Liu","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T15:10:00Z","timestamp":1786029000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614726001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":116,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0165614726001410"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.06.002","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering cells for solid tumor therapy","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}